1 – 2 of 2
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
(
- Contribution to journal › Article